MNPR Triangle 2.JPG
Monopar to Present at the H.C. Wainwright BioConnect Conference
January 07, 2022 07:05 ET | Monopar Therapeutics Inc.
WILMETTE, Ill., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to...
3787276_Codiak_Logo_White_CMYK.jpg
Codiak BioSciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference
January 06, 2022 09:00 ET | Codiak BioSciences, Inc.
CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a...
Imara-Logo-Color-RGB.jpg
Imara to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
January 05, 2022 07:00 ET | Imara, Inc.
BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat subjects...
logo_343x193.png
Yield10 Bioscience to Present at the H.C. Wainwright Bioconnect Virtual Conference
January 04, 2022 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen to Present at H.C. Wainwright Bioconnect Virtual Conference
January 04, 2022 07:00 ET | FibroGen, Inc.
SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the H.C....
logo_343x193.png
Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 09, 2021 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give...
MNPR Triangle 2.JPG
Monopar Therapeutics to Present at Upcoming Investor Conferences in September
September 09, 2021 08:00 ET | Monopar Therapeutics Inc.
WILMETTE, Ill., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Dr. Henry Ji to Participate in the H.C. Wainwright Virtual GLOBAL LIFE SCIENCES CONFERENCE 2021 Investor Conference
March 05, 2021 01:06 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, March 04, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming...
TLC_Tagline.png
TLC to Present at Upcoming Virtual Investor Conferences
March 02, 2021 04:00 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 02, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Dr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor Conference
January 10, 2021 17:58 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming...